SAN FRANCISCO (MarketWatch) -- CryoCor Inc. said after the closing bell on Thursday it has received notification from the Food and Drug Administration that its pre-market approval application for ...

A U.S. advisory panel backed an experimental CryoCor Inc. <CRYO.O> device to treat a type of abnormal heart rhythm, a Food and Drug Administration spokeswoman said on Wednesday.